"CSI is characterized as being a laboratory with very accessible personnel."March 20, 2018A Puerto Rico client shares her experience of working with CSI…Read more →
Dr. Steve Kargas, Director of Surgical Pathology, Earns FACHE CertificationMarch 5, 2018CSI Laboratories is proud to announce that Director of Surgical…Read more →
CSI Laboratories Announces Construction of New Cancer Diagnostics Laboratory in FloridaFebruary 20, 2018CSI Laboratories, a national cancer diagnostics laboratory based…Read more →
New Molecular Testing Guidelines for Lung Cancer PatientsJanuary 26, 2018 A collaboration between the College of American Pathologists…Read more →
What is the Genius MMAP protocol?November 28, 2017 Genius MMAP CSI’s Multiple Myeloma Assessment Protocol…Read more →
Immunotherapy Available for Tumors Identified as dMMR or MSI-HAugust 29, 2017 Patients with unresectable or metastatic solid tumors identified…Read more →
Updated ASCO Guidelines for Stage IV NSCLC Use PD-L1 Testing to Assist in Selection of TherapyAugust 15, 2017 CSI Laboratories offers PD-L1 testing which aids in identifying…Read more →
CSI Laboratories Partnership with Avalon Healthcare Solutions to Benefit Patients in South CarolinaMarch 13, 2017 CSI Laboratories today announced that they have entered into…Read more →
Join Us @ Booth #640 in San Antonio for USCAP 2017March 1, 2017 Join us at USCAP 2017 in San Antonio, Tx, March 6-8.…Read more →
CSI Laboratories’ C•RESULTS Colorectal Carcinoma Panel Mirrors Recently Published Recommendations by ASCP, CAP, AMP, and ASCOFebruary 9, 2017The recent publication of recommendations for molecular biomarkers…Read more →